Here, we present evidence of how leptin can be exploited to derive therapeutic effects in ALS, providing novel insights about the link between leptin and some metabolic disturbances present in TDP‐43A315T mice. This evidence concerns the gene LEP and amyotrophic lateral sclerosis.